Evidence map›Paper›PMID 42293534›Full record

ArticleFrontiers in microbiology2026

Maria Stabile, Anna Esposito, Antonella Migliaccio, Leandra Sepe, Rosaria Artiano, Antonella Ricca, Vita Dora Iula, Raffaele Zarrilli, Annalisa Guaragna, Eliana De Gregorio

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria StabileDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Anna EspositoDepartment of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Antonella MigliaccioDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Leandra SepeDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Rosaria ArtianoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Antonella RiccaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Vita Dora IulaDepartment of Laboratory Medicine, U.O.C Patologia Clinica, Ospedale del Mare-ASL Napoli 1 Centro, Naples, Italy.
Raffaele ZarrilliDepartment of Public Health, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Annalisa GuaragnaDepartment of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Eliana De GregorioDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: The antimicrobial and anti-virulence activity of the iminosugar Results and discussion: L-NPDNJ exhibited weak bactericidal activity but showed additive effects when used in combination with amikacin and tobramycin, reducing their minimum inhibitory concentrations by two- to threefold. At sub-inhibitory concentrations, L-NPDNJ was found to significantly modulate the expression of genes involved in antibiotic resistance, biofilm regulation, and virulence, including those encoding efflux pumps, global regulators, and extracellular proteases. These transcriptional changes were found to be associated with significant phenotypic effects. At sub-inhibitory concentrations, L-NPDNJ reduced cell surface hydrophobicity by up to 90%, impaired adhesion to abiotic surfaces and to human lung epithelial cells by over 90%, and disrupted preformed biofilms, decreasing biofilm biomass and metabolic activity by approximately 70%. In addition, L-NPDNJ has been shown to enhance macrophage phagocytosis and reduce intracellular bacterial survival, while improving epithelial cell viability. Notably, pretreatment of Conclusion: Collectively, these findings demonstrate that L-NPDNJ exerts a broad anti-virulence effect against

Indexed as

adhesion inhibitionanti-virulence drugbiofilm eradicationiminosugarsL-deoxynojirimycinproteases reduction

Identifiers

PMID42293534
PMCPMC13260231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.